Announcement under Regulation 30 (LODR)-Press Release / Media Release
Filed with BSE · · 3 pages · Hindi and English
Summary by 6ix AI
Titan Biotech Limited has announced a special window for the transfer and dematerialisation of physical shares, as detailed in a recent press release. This window is available for a period of one year, allowing shareholders to re-lodge transfer requests and dematerialise shares purchased before a specified date. The announcement is in compliance with a SEBI circular aimed at facilitating ease of investing for shareholders. Copies of the newspaper advertisements regarding this special window have been enclosed with the filing.
Written in English by 6ix AI from the company’s Hindi-language filing. How 6ix writes summaries
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Apr 28 2026
- Titan Biotech Limited Press Release Apr 23 2026
- Titan Biotech Limited Press Release Apr 06 2026
- Titan Biotech Limited Press Release Apr 04 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Titan Biotech
- Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Year Ended March 31, 2026 And To Recommend Dividend, If Any, On The Equity Shares Of The Company For The Financial
- Titan Biotech Limited Press Release May 20 2026
- Board Meeting Outcome for Outcome Of The Board Meeting Of Titan Biotech Limited Held Today I.E. 30Th May, 2026
- Result_Audited Financial Results For The Quarter And Year Ended March 31, 2026
- Corporate Action-Board to consider Dividend
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech